ARA24/Ran enhances the androgen-dependent NH2- and COOH-terminal interaction of the androgen receptor

Biochemical and Biophysical Research Communications

Volumn 373, Issue 3, 2008, Pages 373-377

  Harada, Naoki ^a   Ohmori, Yuji ^a   Yamaji, Ryoichi ^a   Higashimura, Yasuki ^a   Okamoto, Kazuki ^b   Isohashi, Fumihide ^c   Nakano, Yoshihisa ^a   Inui, Hiroshi ^a  

^a Osaka Prefecture University   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Research Center of Health Care Management   (Japan)

Author keywords

Androgen receptor; ARA24 Ran; Coactivator; N C interaction; Nuclear receptor; Prostate; Steroid hormone

Indexed keywords

AMMONIA; ANDROGEN; ANDROGEN RECEPTOR; RAN PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; CYTOPLASM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; MUTANT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN LOCALIZATION; TRANSACTIVATION;

ANDROGENS; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; HUMANS; MALE; MUTATION; PROSTATE; PROSTATIC NEOPLASMS; RAN GTP-BINDING PROTEIN; RECEPTORS, ANDROGEN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC;

EID: 47249093156     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.06.024     Document Type: Article

References (28)

1. Vanderschueren D., Vandenput L., Boonen S., Lindberg M.K., Bouillon R., and Ohlsson C. Androgens and bone. Endocr. Rev. 25 (2004) 389-425
2. Altuwaijri S., Lee D.K., Chuang K.H., Ting H.J., Yang Z., Xu Q., Tsai M.Y., Yeh S., Hanchett L.A., Chang H.C., and Chang C. Androgen receptor regulates expression of skeletal muscle-specific proteins and muscle cell types. Endocrine 25 (2004) 27-32
3. Heinlein C.A., and Chang C. Androgen receptor in prostate cancer. Endocr. Rev. 25 (2004) 276-308
4. Gobinet J., Poujol N., and Sultan Ch. Molecular action of androgens. Mol. Cell. Endocrinol. 198 (2002) 15-24
5. Shen H.C., and Coetzee G.A. The androgen receptor: unlocking the secrets of its unique transactivation domain. Vitam. Horm. 71 (2005) 301-319
6. Doesburg P., Kuil C.W., Berrevoets C.A., Steketee K., Faber P.W., Mulder E., Brinkmann A.O., and Trapman J. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. Biochemistry 36 (1997) 1052-1064
7. He B., Gampe Jr. R.T., Kole A.J., Hnat A.T., Stanley T.B., An G., Stewart E.L., Kalman R.I., Minges J.T., and Wilson E.M. Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance. Mol. Cell 16 (2004) 425-438
8. Thompson J., Saatcioglu F., Janne O.A., and Palvimo J.J. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity. Mol. Endocrinol. 15 (2001) 923-935
9. Ghali S.A., Gottlieb B., Lumbroso R., Beitel L.K., Elhaji Y., Wu J., Pinsky L., and Trifiro M.A. The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity. J. Clin. Endocrinol. Metab. 88 (2003) 2185-2193
10. He B., Gampe Jr. R.T., Hnat A.T., Faggart J.L., Minges J.T., French F.S., and Wilson E.M. Probing the functional link between androgen receptor coactivator and ligand-binding sites in prostate cancer and androgen insensitivity. J. Biol. Chem. 281 (2006) 6648-6663
11. 2-terminal domain. J. Biol. Chem. 274 (1999) 37219-37225
12. 2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth. Mol. Endocrinol. 19 (2005) 350-361
13. Macara I.G. Transport into and out of the nucleus. Microbiol. Mol. Biol. Rev. 65 (2001) 570-594
14. Hsiao P.W., Lin D.L., Nakao R., and Chang C. The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator. J. Biol. Chem. 274 (1999) 20229-20234
15. Buchanan G., Yang M., Cheong A., Harris J.M., Irvine R.A., Lambert P.F., Moore N.L., Raynor M., Neufing P.J., Coetzee G.A., and Tilley W.D. Structural and functional consequences of glutamine tract variation in the androgen receptor. Hum. Mol. Genet. 13 (2004) 1677-1692
16. Harada N., Yasunaga R., Higashimura Y., Yamaji R., Fujimoto K., Moss J., Inui H., and Nakano Y. Glyceraldehyde-3-phosphate dehydrogenase enhances transcriptional activity of androgen receptor in prostate cancer cells. J. Biol. Chem. 282 (2007) 22651-22661
17. 2+ -binding protein, parathymosin) interacts with the glucocorticoid receptor and enhances transcription in vivo. J. Biol. Chem. 280 (2005) 36986-36993
18. 2+ exchanger. Biochim. Biophys. Acta 1593 (2003) 269-276
19. Juzumiene D., Chang C.Y., Fan D., Hartney T., Norris J.D., and McDonnell D.P. Single-step purification of full-length human androgen receptor. Nucl. Recept. Signal. 3 (2005) e001
20. Zhou Z.X., Sar M., Simental J.A., Lane M.V., and Wilson E.M. A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences. J. Biol. Chem. 269 (1994) 13115-13123
21. Harada N., Murata Y., Yamaji R., Miura T., Inui H., and Nakano Y. Resveratrol down-regulates the androgen receptor at the post-translational level in prostate cancer cells. J. Nutr. Sci. Vitaminol. (Tokyo) 53 (2007) 556-560
22. Bevan C.L., Hoare S., Claessens F., Heery D.M., and Parker M.G. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol. Cell. Biol. 19 (1999) 8383-8392
23. He B., Kemppainen J.A., and Wilson E.M. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. J. Biol. Chem. 275 (2000) 22986-22994
24. Schaufele F., Carbonell X., Guerbadot M., Borngraeber S., Chapman M.S., Ma A.A., Miner J.N., and Diamond M.I. The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions. Proc. Natl. Acad. Sci. USA 102 (2005) 9802-9807
25. van Royen M.E., Cunha S.M., Brink M.C., Mattern K.A., Nigg A.L., Dubbink H.J., Verschure P.J., Trapman J., and Houtsmuller A.B. Compartmentalization of androgen receptor protein-protein interactions in living cells. J. Cell Biol. 177 (2007) 63-72
26. Kalab P., Weis K., and Heald R. Visualization of a Ran-GTP gradient in interphase and mitotic Xenopus egg extracts. Science 295 (2002) 2452-2456
27. Li P., Yu X., Ge K., Melamed J., Roeder R.G., and Wang Z. Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer. Am. J. Pathol. 161 (2002) 1467-1474
28. Linja M.J., Porkka K.P., Kang Z., Savinainen K.J., Janne O.A., Tammela T.L., Vessella R.L., Palvimo J.J., and Visakorpi T. Expression of androgen receptor coregulators in prostate cancer. Clin. Cancer Res. 10 (2004) 1032-1040